SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

10x Genomics, Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On:  Monday, 8/8/22, at 7:30pm ET   ·   As of:  8/9/22   ·   For:  6/30/22   ·   Accession #:  1770787-22-49   ·   File #:  1-39035

Previous ‘10-Q’:  ‘10-Q’ on 5/5/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/3/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/3/23 for 9/30/23   ·   5 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/09/22  10x Genomics, Inc.                10-Q        6/30/22   56:5.4M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.08M 
 2: EX-10.1     Material Contract                                   HTML    133K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
12: R1          Cover Page                                          HTML     74K 
13: R2          Condensed Consolidated Balance Sheets               HTML    128K 
14: R3          Condensed Consolidated Statements of Operations     HTML    102K 
15: R4          Condensed Consolidated Statements of Comprehensive  HTML     46K 
                Loss                                                             
16: R5          Condensed Consolidated Statements of Stockholders?  HTML     79K 
                Equity                                                           
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    120K 
18: R7          Description of Business and Basis of Presentation   HTML     24K 
19: R8          Summary of Significant Accounting Policies          HTML     30K 
20: R9          Other Financial Statement Information               HTML    107K 
21: R10         Commitments and Contingencies                       HTML     38K 
22: R11         Capital Stock                                       HTML     24K 
23: R12         Equity Incentive Plans                              HTML     48K 
24: R13         Net Loss Per Share                                  HTML     34K 
25: R14         Subsequent Events                                   HTML     20K 
26: R15         Summary of Significant Accounting Policies          HTML     43K 
                (Policies)                                                       
27: R16         Other Financial Statement Information (Tables)      HTML    120K 
28: R17         Commitments and Contingencies (Tables)              HTML     33K 
29: R18         Equity Incentive Plans (Tables)                     HTML     50K 
30: R19         Net Loss Per Share (Tables)                         HTML     33K 
31: R20         Summary of Significant Accounting Policies -        HTML     19K 
                Additional Information (Detail)                                  
32: R21         Other Financial Statement Information -             HTML     47K 
                Available-for-Sale Securities (Details)                          
33: R22         Other Financial Statement Information - Additional  HTML     36K 
                Information (Detail)                                             
34: R23         Other Financial Statement Information -             HTML     36K 
                Contractual Maturities of Marketable Securities                  
                (Details)                                                        
35: R24         Other Financial Statement Information - Schedule    HTML     28K 
                of Inventory (Detail)                                            
36: R25         Other Financial Statement Information - Schedule    HTML     34K 
                of Accrued Compensation and Related Benefits                     
                (Detail)                                                         
37: R26         Other Financial Statement Information - Schedule    HTML     40K 
                of Accrued Expense And Other Current Liabilities                 
                (Detail)                                                         
38: R27         Other Financial Statement Information - Schedule    HTML     25K 
                of Changes in the Reserve for Product Warranties                 
                (Detail)                                                         
39: R28         Other Financial Statement Information - Revenue     HTML     22K 
                Recognition (Details)                                            
40: R29         Other Financial Statement Information - Schedule    HTML     30K 
                of Revenue by Source (Detail)                                    
41: R30         Other Financial Statement Information - Schedule    HTML     35K 
                of Revenue by Geographic Region (Details)                        
42: R31         Commitments and Contingencies - Additional          HTML     24K 
                Information (Detail)                                             
43: R32         Commitments and Contingencies - Summary of          HTML     40K 
                Company's Operating Lease Liabilities (Detail)                   
44: R33         Commitments and Contingencies - Summary of          HTML     22K 
                Additional Information Related to Operating Leases               
                (Detail)                                                         
45: R34         Capital Stock - Additional Information (Detail)     HTML     32K 
46: R35         Equity Incentive Plans - Additional Information     HTML     29K 
                (Detail)                                                         
47: R36         Equity Incentive Plans - Recorded Stock-Based       HTML     28K 
                Compensation Expense in the Condensed Consolidated               
                Statement of Operations (Details)                                
48: R37         Equity Incentive Plans - Summary of RSU Activity    HTML     41K 
                (Detail)                                                         
49: R38         Equity Incentive Plans - Summary of Company's       HTML     41K 
                Stock Option Activity (Details)                                  
50: R39         Net Loss Per Share - Shares of Common Stock         HTML     35K 
                Equivalents Were Excluded From The Computation of                
                Diluted Net Loss Per Share (Details)                             
51: R40         Subsequent Events (Details)                         HTML     26K 
54: XML         IDEA XML File -- Filing Summary                      XML     95K 
52: XML         XBRL Instance -- txg-20220630_htm                    XML   1.08M 
53: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
 8: EX-101.CAL  XBRL Calculations -- txg-20220630_cal                XML    179K 
 9: EX-101.DEF  XBRL Definitions -- txg-20220630_def                 XML    258K 
10: EX-101.LAB  XBRL Labels -- txg-20220630_lab                      XML   1.06M 
11: EX-101.PRE  XBRL Presentations -- txg-20220630_pre               XML    571K 
 7: EX-101.SCH  XBRL Schema -- txg-20220630                          XSD     99K 
55: JSON        XBRL Instance as JSON Data -- MetaLinks              291±   441K 
56: ZIP         XBRL Zipped Folder -- 0001770787-22-000049-xbrl      Zip    496K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.22.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 151 </ContextCount>
<ElementCount> 231 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 39 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 0001001 - Document - Cover Page </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CoverPage </Role>
<ShortName> Cover Page </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 1001002 - Statement - Condensed Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CondensedConsolidatedBalanceSheets </Role>
<ShortName> Condensed Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 1002003 - Statement - Condensed Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CondensedConsolidatedStatementsofOperations </Role>
<ShortName> Condensed Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 1003004 - Statement - Condensed Consolidated Statements of Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CondensedConsolidatedStatementsofComprehensiveLoss </Role>
<ShortName> Condensed Consolidated Statements of Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 1004005 - Statement - Condensed Consolidated Statements of Stockholders??? Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CondensedConsolidatedStatementsofStockholdersEquity </Role>
<ShortName> Condensed Consolidated Statements of Stockholders??? Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 1005006 - Statement - Condensed Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CondensedConsolidatedStatementsofCashFlows </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 2101101 - Disclosure - Description of Business and Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/DescriptionofBusinessandBasisofPresentation </Role>
<ShortName> Description of Business and Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 2102102 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/SummaryofSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 2105103 - Disclosure - Other Financial Statement Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformation </Role>
<ShortName> Other Financial Statement Information </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 2117104 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CommitmentsandContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 2122105 - Disclosure - Capital Stock </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CapitalStock </Role>
<ShortName> Capital Stock </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 2124106 - Disclosure - Equity Incentive Plans </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/EquityIncentivePlans </Role>
<ShortName> Equity Incentive Plans </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 2130107 - Disclosure - Net Loss Per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/NetLossPerShare </Role>
<ShortName> Net Loss Per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 2133108 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/SubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/SummaryofSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.10xgenomics.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 15 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 2306301 - Disclosure - Other Financial Statement Information (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationTables </Role>
<ShortName> Other Financial Statement Information (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.10xgenomics.com/role/OtherFinancialStatementInformation </ParentRole>
<Position> 16 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 2318302 - Disclosure - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CommitmentsandContingenciesTables </Role>
<ShortName> Commitments and Contingencies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.10xgenomics.com/role/CommitmentsandContingencies </ParentRole>
<Position> 17 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 2325303 - Disclosure - Equity Incentive Plans (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/EquityIncentivePlansTables </Role>
<ShortName> Equity Incentive Plans (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.10xgenomics.com/role/EquityIncentivePlans </ParentRole>
<Position> 18 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 2331304 - Disclosure - Net Loss Per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/NetLossPerShareTables </Role>
<ShortName> Net Loss Per Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.10xgenomics.com/role/NetLossPerShare </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 2404401 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail </Role>
<ShortName> Summary of Significant Accounting Policies - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 2407402 - Disclosure - Other Financial Statement Information - Available-for-Sale Securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationAvailableforSaleSecuritiesDetails </Role>
<ShortName> Other Financial Statement Information - Available-for-Sale Securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 2408403 - Disclosure - Other Financial Statement Information - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationAdditionalInformationDetail </Role>
<ShortName> Other Financial Statement Information - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 2409404 - Disclosure - Other Financial Statement Information - Contractual Maturities of Marketable Securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationContractualMaturitiesofMarketableSecuritiesDetails </Role>
<ShortName> Other Financial Statement Information - Contractual Maturities of Marketable Securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 2410405 - Disclosure - Other Financial Statement Information - Schedule of Inventory (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationScheduleofInventoryDetail </Role>
<ShortName> Other Financial Statement Information - Schedule of Inventory (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 2411406 - Disclosure - Other Financial Statement Information - Schedule of Accrued Compensation and Related Benefits (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationScheduleofAccruedCompensationandRelatedBenefitsDetail </Role>
<ShortName> Other Financial Statement Information - Schedule of Accrued Compensation and Related Benefits (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 2412407 - Disclosure - Other Financial Statement Information - Schedule of Accrued Expense And Other Current Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationScheduleofAccruedExpenseAndOtherCurrentLiabilitiesDetail </Role>
<ShortName> Other Financial Statement Information - Schedule of Accrued Expense And Other Current Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 2413408 - Disclosure - Other Financial Statement Information - Schedule of Changes in the Reserve for Product Warranties (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationScheduleofChangesintheReserveforProductWarrantiesDetail </Role>
<ShortName> Other Financial Statement Information - Schedule of Changes in the Reserve for Product Warranties (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 2414409 - Disclosure - Other Financial Statement Information - Revenue Recognition (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationRevenueRecognitionDetails </Role>
<ShortName> Other Financial Statement Information - Revenue Recognition (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 2415410 - Disclosure - Other Financial Statement Information - Schedule of Revenue by Source (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationScheduleofRevenuebySourceDetail </Role>
<ShortName> Other Financial Statement Information - Schedule of Revenue by Source (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 2416411 - Disclosure - Other Financial Statement Information - Schedule of Revenue by Geographic Region (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/OtherFinancialStatementInformationScheduleofRevenuebyGeographicRegionDetails </Role>
<ShortName> Other Financial Statement Information - Schedule of Revenue by Geographic Region (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 2419412 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CommitmentsandContingenciesAdditionalInformationDetail </Role>
<ShortName> Commitments and Contingencies - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 31 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 2420413 - Disclosure - Commitments and Contingencies - Summary of Company's Operating Lease Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CommitmentsandContingenciesSummaryofCompanysOperatingLeaseLiabilitiesDetail </Role>
<ShortName> Commitments and Contingencies - Summary of Company's Operating Lease Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 2421414 - Disclosure - Commitments and Contingencies - Summary of Additional Information Related to Operating Leases (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CommitmentsandContingenciesSummaryofAdditionalInformationRelatedtoOperatingLeasesDetail </Role>
<ShortName> Commitments and Contingencies - Summary of Additional Information Related to Operating Leases (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 2423415 - Disclosure - Capital Stock - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/CapitalStockAdditionalInformationDetail </Role>
<ShortName> Capital Stock - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 34 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 2426416 - Disclosure - Equity Incentive Plans - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/EquityIncentivePlansAdditionalInformationDetail </Role>
<ShortName> Equity Incentive Plans - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 2427417 - Disclosure - Equity Incentive Plans - Recorded Stock-Based Compensation Expense in the Condensed Consolidated Statement of Operations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/EquityIncentivePlansRecordedStockBasedCompensationExpenseintheCondensedConsolidatedStatementofOperationsDetails </Role>
<ShortName> Equity Incentive Plans - Recorded Stock-Based Compensation Expense in the Condensed Consolidated Statement of Operations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 2428418 - Disclosure - Equity Incentive Plans - Summary of RSU Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/EquityIncentivePlansSummaryofRSUActivityDetail </Role>
<ShortName> Equity Incentive Plans - Summary of RSU Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 2429419 - Disclosure - Equity Incentive Plans - Summary of Company's Stock Option Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/EquityIncentivePlansSummaryofCompanysStockOptionActivityDetails </Role>
<ShortName> Equity Incentive Plans - Summary of Company's Stock Option Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 2432420 - Disclosure - Net Loss Per Share - Shares of Common Stock Equivalents Were Excluded From The Computation of Diluted Net Loss Per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/NetLossPerShareSharesofCommonStockEquivalentsWereExcludedFromTheComputationofDilutedNetLossPerShareDetails </Role>
<ShortName> Net Loss Per Share - Shares of Common Stock Equivalents Were Excluded From The Computation of Diluted Net Loss Per Share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="txg-20220630.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 2434421 - Disclosure - Subsequent Events (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.10xgenomics.com/role/SubsequentEventsDetails </Role>
<ShortName> Subsequent Events (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.10xgenomics.com/role/SubsequentEvents </ParentRole>
<Position> 40 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="txg-20220630.htm"> txg-20220630.htm </File>
<File> txg-20220630.xsd </File>
<File> txg-20220630_cal.xml </File>
<File> txg-20220630_def.xml </File>
<File> txg-20220630_lab.xml </File>
<File> txg-20220630_pre.xml </File>
<File> txg-20220630xex101.htm </File>
<File> txg-20220630xex311.htm </File>
<File> txg-20220630xex312.htm </File>
<File> txg-20220630xex321.htm </File>
<File> txg-20220630xex322.htm </File>
</InputFiles>
<SupplementalFiles>
<File> txg-20220630_g1.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy items="514"> http://fasb.org/us-gaap/2022 </BaseTaxonomy>
<BaseTaxonomy items="30"> http://xbrl.sec.gov/dei/2022 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/15/24  10x Genomics, Inc.                10-K       12/31/23   95:15M
 2/16/23  10x Genomics, Inc.                10-K       12/31/22   93:23M

3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/26/20  10x Genomics, Inc.                8-K:5,9     3/26/20    2:130K                                   Donnelley … Solutions/FA
 9/16/19  10x Genomics, Inc.                8-K:3,5,7,8 9/13/19    4:207K                                   Donnelley … Solutions/FA
 8/19/19  10x Genomics, Inc.                S-1                   24:13M                                    Donnelley … Solutions/FA
↑Top
Filing Submission 0001770787-22-000049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., Apr. 29, 1:39:02.1am ET